Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combination With Loop Diuretics for Diuretic Resistant Decompensated Heart Failure

Trial Profile

Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combination With Loop Diuretics for Diuretic Resistant Decompensated Heart Failure

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Dec 2016

At a glance

  • Drugs Chlorothiazide (Primary) ; Tolvaptan (Primary) ; Metolazone
  • Indications Hypervolaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Oct 2016 Planned End Date changed from 1 Sep 2018 to 1 Mar 2019.
    • 31 Oct 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Mar 2018.
    • 18 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top